Feshchenko YuI Melnyk VM Novozhilova IO Lyrnyk SV The mortality of patients with tuberculosis: structure, dynamics and peculiarities in epidemic period Ukr Pulmonol J 2009 3 5-9 
Nikolayevskyy VV Brown TJ Bazhora YI Asmolov AA Balabanova YM Drobniewski FA Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine Clin Microbiol Infect 2007 13 129-138 
Atun R Olynik I Resistance to implementing policy change: the case of Ukraine Bulletin of World Health Organization 2008 86 147-154 
Batdelger D Dandii D Jirathitikal V Bourinbaiar AS Open label trial of therapeutic hepatitis B vaccine V-5 Immunitor (V5) delivered by oral route Lett Drug Design Discovery 2007 4 540-544 
Batdelger D Dandii D Jirathitikal V Bourinbaiar AS Open label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C Vaccine 2008 26 2733-2737 
Batdelger D Dandii D Dahgwahdorj Ya Erdenetsogt E Oyunbileg J Tsend N Bayarmagnai B Jirathitikal V Bourinbaiar AS Clinical experience with therapeutic vaccines designed for patients with hepatitis Curr Pharm Design 2009 15 1159-1171 
Arjanova OV Prihoda ND Yurchenko LV Sokolenko NI Frolov VM Tarakanovskaya MG Jirathitikal V Bourinbaiar AS Phase 2 trial of V-5 Immunitor (V5) in patients with chronic hepatitis C co-infected with HIV and Mycobacterium tuberculosis J Vaccin Vaccinat 2010 1 103 
Arjanova OV Prihoda ND Yurchenko LV Sokolenko NI Frolov VM Tarakanovskaya MG Batdelger D Jirathitikal V Bourinbaiar AS Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV co-infected TB Immunotherapy in press
Reitman S Frankel S A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases Am J Clin Pathol 1957 28 56-63 
Ostrovski&#301; VK Asanov BM Iangolenko DV Some blood indices and the leukocytic index of intoxication in tuberculosis, pneumonias, abscesses, and cancer of the lung Probl Tuberk Bolezn Legk 2005 3 43-46 
Zaitzeva SI Matveeva SL Gerasimova TG Pashkov YN Butov DA Pylypchuk VS Frolov VM Kutsyna GA Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo Clin Microbiol Infect 2009 15 1154-1162 
Veenstra H Baumann R Carroll NM Lukey PT Kidd M Beyers N Bolliger CT van Helden PD Walzl G Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders Clin Exp Immunol 2006 145 252-260 
Saukkonen JJ Cohn DL Jasmer RM Schenker S Jereb JA Nolan CM Peloquin CA Gordin FM Nunes D Strader DB Bernardo J Venkataramanan R Sterling TR ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee An official ATS statement: hepatotoxicity of antituberculosis therapy Am J Respir Crit Care Med 2006 174 935-952 
Vasantha M Gopi PG Subramani R Weight gain in patients with tuberculosis treated under directly observed treatment short-course (DOTS) Indian J Tuberc 2009 56 5-9 
Yew WW Leung CC Prognostic significance of early weight gain in underweight patients with tuberculosis Am J Respir Crit Care Med 2006 174 236-237 
Majumdar A Kamble PD Harinath BC Detection of circulating free and immune-complexed antigen in pulmonary tuberculosis using cocktail of antibodies to Mycobacterium tuberculosis excretory secretory antigens by peroxidase enzyme immunoassay Indian J Tuberc 2010 57 67-74 
Vilaplana C Montan&#233; E Pinto S Barriocanal AM Domenech G Torres F Cardona PJ Costa J Double-blind, randomized, placebo-controlled Phase I clinical trial of the therapeutical antituberculous vaccine RUTI Vaccine 2010 28 1106-1116 
Stanford J Stanford C Grange J Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis Front Biosci 2004 9 1701-1719 
Zhao G-R Feng D-H A systematic review of inactivated Mycobacterium phlei injection for adjunctive treatment of drug resistant pulmonary tuberculosis Pharm J Chin PLA 2009 25 361-364 
Nyasulu PS Role of adjunctive Mycobacterium w immunotherapy for tuberculosis J Exp Clin Med 2010 2 123-129 
Svistunova AS Pinegin BV Selitskaia RP Arshinova SS Klimova EG Andronova TM Batyrov FA Simonova AV The use of immunomodulator likopid in the combined treatment pulmonary tuberculosis Probl Tuberk 2002 3 21-25 
Lei JP Xiong GL Hu QF Li Y Zong PL Tu SH Tu RY Immunotherapeutic efficacy of BCG vaccine in pulmonary tuberculosis and its preventive effect on multidrug-resistant tuberculosis Zhonghua Yu Fang Yi Xue Za Zhi 2008 42 86-89 
Kaufmann SH Is the development of a new tuberculosis vaccine possible? Nat Med 2000 6 955-960 
Kato S Tokunaga O Yoshiyama T Analysis of Koch's phenomenon by BCG vaccination with the multi-puncture method in Japan Kekkaku 2010 85 782-785 
Repique CJ Li A Collins FM Morris SL DNA Immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge Infect Immun 2002 70 3318-3323 
Moreira AL Tsenova L Aman MH Bekker L-G Freeman S Mangaliso B Schr&#246;der U Jagirdar J Rom WN Tovey MG Freedman VH Kaplan G Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice Infect Immun 2002 70 2100-2107 
Basaraba RJ Izzo AA Brandt L Orme IM Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations Vaccine 2006 24 280-286 
Radaeva TV Nikonenko BV Kapina MA Mishchenko VV Apt AS Experimental approaches to designing vaccines against tuberculous infection reactivation Probl Tuberk Bolezn Legk 2006 5 45-48 
Cruz A Fraga AG Fountain JJ Rangel-Moreno J Torrado E Saraiva M Pereira DR Randall TD Pedrosa J Cooper AM Castro AG Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis J Exp Med 2010 207 1609-1616 
Derrick SC Perera LP Dheenadhayalan V Yang A Kolibab K Morris SL The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis Vaccine 2008 26 6092-6098 
Roth AE Benn CS Ravn H Rodrigues A Lisse IM Yazdanbakhsh M Whittle H Aaby P Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau BMJ 2010 340 c671 
Silin DS Lyubomska OV Jirathitikal V Bourinbaiar AS Oral vaccination: where we are? Expert Opin Drug Deliv 2007 4 323-340 
Zaitzeva SI Matveeva SL Gerasimova TG Pashkov YuN Butov DA Pylypchuk VS Frolov VM Kutsyna GA Efficacy and safety of phytoconcentrate Dzherelo (Immunoxel) in treatment of patients with multi-drug resistant TB (MDR-TB) in comparison to standard chemotherapy Res J Med Sci 2009 3 36-41 
Churchyard GJ Kaplan G Fallows D Wallis RS Onyebujoh P Rook GA Advances in immunotherapy for tuberculosis treatment Clin Chest Med 2009 30 769-782 
Thaiss CA Kaufmann SH Toward novel vaccines against tuberculosis: current hopes and obstacles Yale J Biol Med 2010 83 209-215 
Dheda K Schwander SK Zhu B van Zyl-Smit RN Zhang Y The immunology of tuberculosis: from bench to bedside Respirology 2010 15 433-450 
Biochemie and Pathobiochemie 7th Springer Berlin, Heidelberg, New York 2003 
Samuelsson B. Morgenstern R. Jakobsson P. J. Membrane prostaglandin E synthase-1: a novel therapeutic target Pharmacol. Rev. 2007 59 
Mehrotra S. Morimiya A. Agarwal B. Konger R. Badve S. Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy J. Pathol. 2006 208 
Friesen R. W. Mancini J. A. Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target J. Med. Chem. 2008 51 
Thoren S. Jakobsson P. J. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4 Eur. J. Biochem. 2000 267 
Quraishi O. Mancini J. A. Riendeau D. Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids Biochem. Pharmacol. 2002 63 
Riendeau D. Aspiotis R. Ethier D. Gareau Y. Grimm E. L. Guay J. Guiral S. Juteau H. Mancini J. A. Methot N. Rubin J. Friesen R. W. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886 Bioorg. Med. Chem. Lett. 2005 15 
AbdulHameed M. D. Hamza A. Liu J. Huang X. Zhan C. G. Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure&#8211;activity correlation J. Chem. Inf. Model. 2008 48 
Cote B. Boulet L. Brideau C. Claveau D. Ethier D. Frenette R. Gagnon M. Giroux A. Guay J. Guiral S. Mancini J. Martins E. Masse F. Methot N. Riendeau D. Rubin J. Xu D. Yu H. Ducharme Y. Friesen R. W. Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors Bioorg. Med. Chem. Lett. 2007 17 
Claveau D. Sirinyan M. Guay J. Gordon R. Chan C. C. Bureau Y. Riendeau D. Mancini J. A. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model J. Immunol. 2003 170 
San Juan A. A. Cho S. J. 3D-QSAR study of microsomal prostaglandin E2 synthase (mPGES-1) inhibitors J. Mol. Model. 2007 13 
Jakobsson P. J. Morgenstern R. Mancini J. Ford-Hutchinson A. Persson B. Common structural features of MAPEG&#8212;a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism Protein Sci. 1999 8 
Jegerschold C. Pawelzik S. C. Purhonen P. Bhakat P. Gheorghe K. R. Gyobu N. Mitsuoka K. Morgenstern R. Jakobsson P. J. Hebert H. Structural basis for induced formation of the inflammatory mediator prostaglandin E2 Proc. Natl. Acad. Sci. U.S.A. 2008 105 
Rorsch F. Wobst I. Zettl H. Schubert-Zsilavecz M. Grosch S. Geisslinger G. Schneider G. Proschak E. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol J. Med. Chem. 2010 53 
Koeberle A. Zettl H. Greiner C. Wurglics M. Schubert-Zsilavecz M. Werz O. Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase J. Med. Chem. 2008 51 
Hessler G. Baringhaus K.-H. The scaffold hopping potential of pharmacophores Drug Discovery Today: Technol. 2010 7 
K&#246;berle A. Zettl H. Greiner C. Wurglics M. Schubert-Zsilavecz M. Werz O. Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase J. Med. Chem. 2008 51 
Int. Pat. Appl. PCT WO 2005/123673 A1 29 Dec 2005 
Int. Pat. Appl. PCT WO 2005/123675 A1 29 Dec 2005 
Edwards B. S. Bologa C. Young S. M. Balakin K. V. Prossnitz E. R. Savchuck N. P. Sklar L. A. Oprea T. I. Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists Mol. Pharmacol. 2005 68 
Rohrer S. G. Baumann K. Maximum unbiased validation (MUV) data sets for virtual screening based on PubChem bioactivity data J. Chem. Inf. Model. 2009 49 
Chen C. Y.-C. Pharmacoinformatics approach for mPGES-1 in anti-inflammation by 3D-QSAR pharmacophore mapping J. Taiwan Inst. Chem. Eng. 2009 40 
Celotti F. Laufer S. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept Pharmacol. Res. 2001 43 
Koeberle A. Siemoneit U. Buhring U. Northoff H. Laufer S. Albrecht W. Werz O. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1 J. Pharmacol. Exp. Ther. 2008 326 
Peters-Golden M. Henderson W. R. Jr. Leukotrienes N. Engl. J. Med. 2007 357 
Hopkins A. L. Network pharmacology: the next paradigm in drug discovery Nature Chem. Biol. 2008 4 
Fischer L. Szellas D. Radmark O. Steinhilber D. Werz O. Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors FASEB J. 2003 17 
Werz O. Burkert E. Samuelsson B. Radmark O. Steinhilber D. Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes Blood 2002 99 
Getz L Sigurdsson JA Hetlevik I Is opportunistic disease prevention in the consultation ethically justifiable? BMJ 2003 327 498-500 
G&#233;rvas J Heath I Dur&#225;n A Clinical prevention: patients' fear and the doctor's guilt Eur J Gen Pract 2009 15 122-4 
Whitt LA Value-bifurcation in bioscience: the rhetoric of research justification Perspective on Science 1999 7 413-46 
Pauli HG White KL McWhinney IR Medical education, research, and scientific thinking in the 21st century (part one of three) Educ Health (Abingdon) 2000 13 15-25 
Kuhn TS The structure of scientific revolutions 2nd edn Chicago University of Chicago Press 1970 
Nowotny H Scott P Gibbons M Rethinking science. Knowledge and the public in an age of uncertainty Oxford Blackwell Publishers 2001 
Funtowicz SO Ravetz JR Science for the post-normal age Futures 1993 25 739-55 
Haraway D Situated knowledges: the science question in feminism and the privilege of partial perspective Haraway D Simians, cyborgs, and women. The reinvention of nature New York Routledge 1991 182-201 
Kenen RH The at-risk status and technology: a diagnostic invitation and the &#8216;gift&#8217; of knowing Soc Sci Med 1996 42 145-53 
Sibbald B Bojke C Gravelle H National survey of job satisfaction and retirement intentions among general practitioners in England BMJ 2003 326 22-4 
Freeman AC Sweeny K Why general practitioners do not implement evidence: a qualitative study BMJ 2001 323 1100-2 
Gubb JD Commentary: unintended consequences: what of quality outside the QOF? Br J Gen Pract 2009 59 e173-4 
Fisher ES Welch HG Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA 1999 281 446-53 
Reventlow SD Hvas L Malterud K Making the invisible body visible. Bone scans, osteoporosis and women's bodily experiences Soc Sci Med 2006 62 2720-31 
Hofmann B On the value-ladenness of technology in medicine Med Health Care Philos 2001 4 335-46 
Hetlevik I Evidence-based medicine in general practice: a hindrance to optimal medical care? Scand J Prim Health Care 2004 22 136-40 
Kirkengen AL Ulvestad E [Heavy burdens and complex disease &#8211; an integrated perspective] Tidsskr Nor Laegeforen 2007 127 3228-31 http://www.tidsskriftet.no/index.php?seks_id_eng=14150&amp;seks_id=1628567 
Moynihan R Smith R Too much medicine? Almost certainly BMJ 2002 324 859-60 
Gerv&#225;s J Starfield B Heath I Is clinical prevention better than cure? Lancet 2008 372 1997-9 
Malterud K The legitimacy of clinical knowledge: towards a medical epidemiology embracing the art of medicine Theor Med 1995 16 183-98 
McWhinney IR Primary care: core values. Core values in a changing world BMJ 1998 316 1807-9 
Patsopoulus NA Analatos A Ioannidis JP Origin and funding of the most frequently cited papers in medicine: database analysis BMJ 2006 332 1061-4 
Agnell M Industry-sponsored clinical research. a broken system JAMA 2008 300 1069-71 
Patel V Cultural factors and international epidemiology Br Med Bull 2001 57 33-45 
Foucault M Gordon C Power/knowledge: selected interviews and other writings 1972&#8211;77 Brighton Harvester Press 1980 
Dean K The role of methods in maintaining orthodox beliefs in health research Soc Sci Med 2004 58 675-85 
Royal Society, Royal Academy of Engineering Nanosciences and Nanotechnologies: opportunities and uncertainties 2004 http://www.nanotec.org.uk/finalReport.htm 
Wait J. R. IEEE J. Oceanic Eng. 1977 2 161-172 
Brillouin L. Wave Propagation and Group Velocity 1960 Academic Press New York 
Taylor J. D. Introduction to Ultra-Wideband Radar Systems 1994 CRC Press New York 
Barrett T. W. Energy Transfer &amp; Propagation and the Dielectrics of Materials: Transient Versus Steady State Effects. Proceedings of the First Los Alamos Symposium 1991 CRC New York 
Fowler C. Entzminger J. Corum, J. IEEE Aerosp. Electron. Syst. Mag. 1990 5 11 45-48 
Fowler C. A. IEEE Aerosp. Electron. Syst. Mag. 1992 12 3-5 
Griffiths H.D. Baker C.J. Fernandez A. Davies J.B. Cullen A.L. Use and Application of Precursor Waveforms. 1st EMRS DTC Technical Conference, Edinburgh 2004 
Olson T. Precursor-based HRR for Foliage Penetration: a 10&#8211;15dB Win. AFOSR Electromaghetics Workshop, San Antonio, January 8&#8211;10 2004 
Olson T. Precursor-based HRR for Foliage Penetration; Technical Report 2003 The University of Florida 
Black D. L. IEEE Aerosp. Electron. Syst. Mag. 1992 1 320-326 
Choi S. H. &#214;sterberg U. L. Phys. Rev. Lett. 2004 92 193903 
Fox A. E. &#214;sterberg U. L. Opt. Express. 2006 14 3689-3693 
Lukofsky D. Jeong H. Bessette J. &#214;sterberg U. PIERS Online. 2008 4 854-858 
&#214;sterberg U.L. Andersson D. Lisak M. Opt. Commun. 2007 277 5-13 
Li J. C. Alexander D. R. Shang H. F. Parali U. Doerr D. W. Bruce J. C. III Wang H. Opt. Express. 2007 15 1939-1945 
Okawachi Y. Slepkov A. D. Agha I. H. Geraghty D. F. Gaeta A. L. J. Opt. Soc. Am. A 2007 24 3343-3347 
Roberts T. M. Phys. Rev. Lett. 2004 92 193903 
Alfano R. R. Birman J. L. Ni X. Alrubaiee M. Das B. B. Phys. Rev. Lett. 2005 94 239401-1-5 
Ni X. Alfano R. R. Opt. Express. 2006 94 4188-4194 
Jeong H. Dawes A. M. C. Gauthier D. J. Phys. Rev. Lett. 2006 96 143901-1-4 
Pleshko P. Palocz I. Phys. Rev. Lett. 1969 22 1201-1204 
Klauder J. R. IEE P-Radar Son Nav. 2005 152 23-28 
Gibson U. J. &#214;sterberg U.L. Opt. Express. 2005 13 2105-2110 
Jackson J. D. Classical Electrodynamics 1975 Wiley New York 
Oughstun K. E. Balictsis C. M. Phys. Rev. Lett. 1996 77 2210-2213 
Schulz-Dubois E. O. IEEE Trans. Microwave Theory Tech. 1970 18 455-460 
Stenius P. York B. IEEE Antennas Propag. Mag. 1995 37 39-44 
Allen L. Eberly J. H. Optical Resonance and Two-Level Atoms 1987 Dover Publications New York 
Oughstun K. E. Sherman G. E. Electromagnetic Pulse Propagation in Causal Dielectrics 1994 Springer-Verlag Berlin 
Roberts T. M. Electron. Lett. 2002 38 679-680 
Fraser-Smith A. C. Bubenik D. M. Villard O. G. Jr Air/undersea Communication at Ultra-low-frequencies Using Airborne Loop Antennas; Technical Report 4207-6 1977 Stanford, CA Stanford University Electronics Laboratory 
Ziolkowski R. W. Arnold J. M. Gogny D. M. Phys. Rev. A 1995 52 3082-3092 
Stenger J. Madsen D. Hamm P. Nibbering E. Elsaesser T. Phys. Rev. Lett. 2001 87 27401 
Gale G. Gallot G. Hache F. Lascoux N. Phys. Rev. Lett. 1999 82 1068-1071 
Callegari A. Theule P. Muenter J. Tolchenov R. Zobov N. Polyansky O. Tennyson J. Rizzo T. Science 2002 297 993-995 
Segelstein D.J. The Complex Refractive Index of Water. Master's Thesis, University of Missouri, Kansas City, MO, USA 1981 
Crisp M. D. Phys. Rev. A 1969 1 1605-1611 
Vogel A. Noack J. Nahen K. Theisen D. Busch S. Parlitz U. Hammer D. Noojin G. Rockwell B. Birngruber R. Phys. Rev. B 1999 68 271-280 
McCall S. L. Hahn E. L. Phys. Rev. 1969 183 452-457 
Aalbers MB What types of neighbourhoods are redlined? Journal of Housing and the Built Environment 2007 22 177-198 
Aassve A Billari FC Mazzuco S Ongaro F Leaving home: A comparative analysis of ECHP data Journal of European Social Policy 2002 12 259-275 
Allison PD Discrete-time methods for the analysis of event histories Sociological Methodology 1982 13 61-98 
Aquilino WS Family structure and home-leaving: A further specification of the relationship Journal of Marriage and the Family 1991 53 999-1010 
Avery R Goldscheider F Speare A Jr Feathered nest/gilded cage: Parental income and leaving home in the transition to adulthood Demography 1992 29 375-388 
Bernhardt E Gahler M Goldscheider F Childhood family structure and routes out of the parental home in Sweden Acta Sociologica 2005 48 99-115 
Bernhardt E Goldscheider G Goldscheider F Bjeren G Immigration, gender and family transitions to adulthood in Sweden 2007 Lanham University Press of America 
Billari FC Liefbroer AC Should I stay or should I go? The impact of age norms on leaving home Demography 2007 44 181-198 
Blossfeld H-P Huinink J Human capital investments or norms of role transition? How women&#8217;s schooling and career affect the process of family formation American Journal of Sociology 1991 97 143-168 
Bolt G Turkish and Moroccan couples and their first steps on the Dutch housing market: Co-residence or independence? Journal of Housing and the Built Environment 2002 17 269-292 
Buck N Scott J She&#8217;s leaving home: But why? An analysis of young people leaving the parental home Journal of Marriage and the Family 1993 55 863-874 
Dalla Zuanna G The banquet of aeolus: A familistic interpretation of Italy&#8217;s lowest low fertility Demographic Research 2001 4 article 5 133-162 
Jong Gierveld J Liefbroer AC Beekink E The effect of parental resources on patterns of leaving home among young adults in the Netherlands European Sociological Review 1991 7 55-71 
Valk HAG Crul M , Heering L Union and family formation The position of the Turkish and Moroccan second generation in Amsterdam and Rotterdam 2008 Amsterdam Amsterdam University Press 143-159 
Valk HAG Billari FC Living arrangements of migrant and Dutch young adults: The family influence disentangled Population Studies 2007 61 201-217 
Valk HAG Liefbroer AC Parental influence on union formation preferences among Turkish, Moroccan, and Dutch adolescents in the Netherlands Journal of Cross-Cultural Psychology 2007 38 487-505 
Valk HAG Liefbroer AC Timing preferences for women&#8217;s family-life transitions: Intergenerational transmission among migrants and Dutch Journal of Marriage and Family 2007 69 190-206 
Ermisch J Prices, parents and young people&#8217;s household formation Journal of Urban Economics 1999 45 47-71 
Giuliano P Living arrangements in Western Europe: Does cultural origin matter? Journal of the European Economic Association 2007 5 927-952 
Glick JE Hook J Parents&#8217; coresidence with adult children: Can immigration explain racial and ethnic variation? Journal of Marriage and Family 2002 64 240-253 
Goldscheider FK Goldscheider C The historical trajectory of the black family: Ethnic differences in leaving home over the twentieth century The History of the Family 1997 2 295-307 
Goldscheider F Goldscheider C The changing transition to adulthood. Leaving and returning home 1999 Thousand Oaks Sage 
Goldscheider F Thornton A Young-DeMarco L A portrait of the nest leaving process in early adulthood Demography 1993 30 683-699 
Haurin RJ Haurin DR Hendershott PH Bourassa SC Home or alone: The costs of independent living for youth Social Science Research 1997 26 135-152 
Koc I The timing of leaving parental home and its linkages to other life course events in Turkey Marriage &amp; Family Review 2007 42 29-47 
Lancaster T The econometric analysis of transition data 1990 Cambridge Cambridge University Press 
Lesthaeghe R Surkyn J Cultural dynamics and economic theories of fertility change Population and Development Review 1988 14 1-45 
McLanahan S Diverging destinies: How children are faring under the second demographic transition Demography 2004 41 607-627 
Merz EM Ozeke-Kocabas E Oort FJ Schuengel C Intergenerational family solidarity: Value differences between immigrant groups and generations Journal of Family Psychology 2009 23 291-300 
Mitchell BA Wister AV Gee EM The ethnic and family nexus of homeleaving and returning among Canadian young adults Canadian Journal of Sociology 2004 29 543-576 
Mulder CH Clark WAV Leaving home and leaving the state: Evidence from the United States International Journal of Population Geography 2000 6 423-437 
Mulder CH Hooimeijer P Leaving home in the Netherlands: Timing and first housing Journal of Housing and the Built Environment 2002 17 237-268 
Murphy M Wang D Family and sociodemographic influences on patterns of leaving home in postwar Britain Demography 1998 35 293-305 
Nilsson K Strandh M Nest leaving in Sweden: The importance of early educational and labor market careers Journal of Marriage and the Family 1999 61 1068-1079 
Raley RK Increasing fertility in cohabiting unions: Evidence for the second demographic transition in the United States? Demography 2001 38 59-66 
Beek KWH Koopmans CC Praag BMS Shopping at the labour market: A real tale of fiction European Economic Review 1997 4 295-31 
Kaa DJ Europe&#8217;s second demographic transition Population Bulletin 1987 42 1-57 
Whittington LA Peters HE Economic incentives for financial and residential independence Demography 1996 33 82-97 
Morton DL Wen DR Wong JH Technical details of intraoperative lymphatic mapping for early stage melanoma Archives of Surgery 1992 127 4 392-399 
McMasters KM Dirk Noyes R Reintgen DS Lessons learned from the sunbelt melanoma trial Journal of Surgical Oncology 2004 86 4 212-223 
Bagaria SP Faries MB Morton DL Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute Journal of Surgical Oncology 2010 101 8 669-676 
Uhara H Takata M Saida T Sentinel lymph node biopsy in Japan International Journal of Clinical Oncology 2009 14 6 490-496 
McMasters KM Chao C Wong S Interval sentinel lymph nodes in melanoma Archives of Surgery 2002 137 5 543-549 
Silverio A McRae M Ariyan S Narayan D Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma Annals of Plastic Surgery 2010 65 4 418-424 
Morton DL Thompson JF Alistair MD Sentinel-node biopsy or nodal observation in melanoma New England Journal of Medicine 2006 355 13 1307-1317 
Xing Y Badgwell BD Ross MI Lymph node ratio predicts disease-specific survival in melanoma patients Cancer 2009 115 11 2505-2513 
Uren RF Howman-Giles R Thompson JF Interval nodes: the forgotten sentinel nodes in patients with melanoma Archives of Surgery 2000 135 10 1168-1172 
Thompson JF Uren RF Shaw HM Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy Journal of the American College of Surgeons 1999 189 2 195-204 
Vidal-Sicart S Pons F Fuertes S Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? European Journal of Nuclear Medicine and Molecular Imaging 2004 31 7 945-949 
Lens M Sentinel lymph node biopsy in melanoma patients JEADV 2010 24 9 1005-1012 
Manganoni AM Farisoglio C Facchetti F Simoncini E Calzavara Pinton PG Sentinel lymph node biopsy in melanoma: assessment of risk Annals of Surgical Oncology 2008 15 9 p. 2626 
Balch CM Gershenwald JE Soong SJ Final version of 2009 AJCC melanoma staging and classification Journal of Clinical Oncology 2009 27 36 6199-6206 
Gershenwald JE Soong SJ Balch CM 2010 TNM staging system for cutaneous melanoma...and beyond Annals of Surgical Oncology 2010 17 1475-1477 
Vu&#269;eti&#263; B Rogan SA Balenovi&#263; A The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma Wiener Klinische Wochenschrift 2006 118 9-10 286-293 
Vidal-Sicart S Pons F Piulachs J Castel T Palou J Herranz R Mid-arm sentinel lymph nodes showing surprising drainage from a malignant melanoma in the forearm Clinical Nuclear Medicine 1998 23 5 273-274 
Norman J Cruse CW Espinosa C Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma American Journal of Surgery 1991 162 5 432-437 
Uren RF Howman-Giles RB Thompson JF Shaw HM McCarthy WH Lymphatic drainage from periumbilical skin to internal mammary nodes Clinical Nuclear Medicine 1995 20 3 254-255 
Roozendaal GK De Vries JDH Van Poll D Sentinel nodes outside lymph node basins in patients with melanoma British Journal of Surgery 2001 88 2 305-308 
Matsumoto T Shibata S Yasue S Interval sentinel lymph nodes in patients with cutaneous melanoma: a single-institution study in Japan Journal of Dermatology 2010 37 7 629-634 
Banai K Ahissar M Auditory processing deficits in dyslexia: task or stimulus related? Cerebral Cortex 2006 16 1718-1728 
Ba&#351;ar E Ba&#351;ar-Eroglu C Karakas S Sch&#252;rmann M Oscillatory brain theory: a new trend in neuroscience IEEE Engineering in Medicine and Biology 1999 18 56-66 
Ba&#351;ar E Ba&#351;ar-Eroglu C Parnefjord R Rahn E Sch&#252;rmann M Ba&#351;ar E , Bullock TH Evoked potentials: ensembles of brain induced rhythmicities in the alpha, theta and gamma ranges Induced rhythms in the brain 1992 Boston, MA Birkhauser 155-181 
Bishop DVM The Test for Reception of Grammar, version 2 (TROG-2) 2003 London Pearson 
Bishop DVM Hardiman MJ Measurement of mismatch negativity in individuals: a study using single-trial analysis Psychophysiology 2010 47 697-705 
Bishop DVM Hardiman M Uwer R von Suchodoletz W Maturation of the long-latency auditory ERP: step function changes at start and end of adolescence Developmental Science 2007 10 576-587 
Boersma P Weenink D Praat: a system for doing phonetics by computer Glot International 2005 5 9/10 341-345 
Buss E Hall JW Grose JH Psychometric functions for pure tone intensity discrimination: slope differences in school-aged children and adults Journal of the Acoustical Society of America 2009 125 1050-1058 
&#268;eponien&#233; R Lepist&#246; T Soininen M Aronen E Alku P N&#228;&#228;t&#228;nen R Event-related potentials associated with sound discrimination versus novelty detection in children Psychophysiology 2004 41 130-141 
Cheour M Korpilahti P Martynova O Lang AH Mismatch negativity and late discriminative negativity in investigating speech perception and learning in children and infants Audiology and Neuro-Otology 2001 6 2-11 
Cheour M Lepp&#228;nen PH Kraus N Mismatch negativity (MMN) as a tool for investigating auditory discrimination and sensory memory in infants and children Clinical Neurophysiology 2000 111 4-16 
Craig C GoldWave (Version 5.23) 2008 St Johns, Newfoundland GoldWave Inc [Sound Editing Program]
Delorme A Makeig S EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis (sccn.ucsd.edu/eeglab/) Journal of Neuroscience Methods 2004 134 9-21 
Eggermont JJ Ponton CW Auditory-evoked potential studies of cortical maturation in normal hearing and implanted children: correlations with changes in structure and speech perception Acta Otolaryngologica 2003 123 249-252 
Field A Discovering statistics using SPSS 2005 2nd edn London Sage Publications 
Findlay JM Estimates on probability functions: a more virulent PEST Perception and Psychophysics 1978 23 181-185 
Fuentemilla L Marco-Pallar&#233;s J Grau C Modulation of spectral power and phase resetting of EEG contributes differentially to the generation of auditory event-related potentials NeuroImage 2006 30 909-916 
Fuentemilla L Marco-Pallar&#233;s J M&#252;nte TF Grau C Theta EEG oscillatory activity and auditory change detection Brain Research 2008 1220 93-101 
Gomot M Giard MH Roux S Barthelemy C Bruneau N Maturation of frontal and temporal components of mismatch negativity (MMN) in children NeuroReport 2000 11 3109-3112 
Guthrie D Buchwald J Significance testing of difference potentials Psychophysiology 1991 28 240-244 
Halliday L Bishop DVM Frequency discrimination and literacy skills in children with mild to moderate sensorineural hearing loss Journal of Speech, Language and Hearing Research 2005 48 1187-1203 
Heath SM Bishop DVM Hogben JH Roach NW Psychophysical indices of perceptual functioning in dyslexia: a psychometric analysis Cognitive Neuropsychology 2006 23 905-929 
Hsiao FJ Wu ZA Ho LT Lin YY Theta oscillation during auditory change detection: an MEG study Biological Psychology 2009 81 1 58-66 
Illing R Maturation and plasticity of the central auditory system Acta Otolaryngol Suppl. 2004 552 6-10 
Kolev V Rosso OA Yordanova J A transient dominance of theta ERP component characterizes passive auditory processing: evidence from a developmental study NeuroReport 2001 12 2791-2796 
Korpilahti P Krause CM Holopainen IE Lang AH Early and late mismatch negativity elicited by words and speech-like stimuli in children Brain and Language 2001 76 332-339 
Kraus N Koch DB McGee TJ Nicol TG Cunningham J Speech&#8211;sound discrimination in school-age children: psychophysical and neurophysiological measures Journal of Speech, Language, and Hearing Research 1999 42 1042-1060 
Kraus N McGee T Carrell T Sharma A Micco A Nicol T Speech-evoked cortical potentials in children Journal of the American Academy of Audiology 1993 4 238-248 
Lenroot RK Schmitt JE Ordaz SJ Wallace GL Neale MC Lerch JP Kendler KS Evans AC Giedd JN Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence Human Brain Mapping 2009 30 163-174 
McGee T Kraus N Nicol T Is it really a mismatch negativity? An assessment of methods for determining response validity in individual subjects Electroencephalography and Clinical Neurophysiology 1997 104 359-368 
Makeig S Auditory event-related dynamics of the EEG spectrum and effects of exposure to tones Electroencephalography and Clinical Neurophysiology 1993 86 283-293 
Makeig S Debener S Onton J Delorme A Mining event-related brain dynamics Trends in Cognitive Sciences 2004 8 204-210 
Moore DR Auditory development and the role of experience British Medical Bulletin 2002 63 171-181 
Moore JK Guan Y Cytoarchitectural and axonal maturation in human auditory cortex Journal of the Association for Research in Otolaryngology 2001 2 297-311 
Moore JK Linthicum FH The human auditory system: a timeline of development International Journal of Audiology 2007 46 460-478 
M&#252;lller V Gruber W Klimesch W Lindenberger U Lifespan differences in cortical dynamics of auditory perception Developmental Science 2009 12 839-853 
N&#228;&#228;t&#228;nen R Lehtokoski A Lennes M Cheour M Huotilainen M Ilvonen A Vainio M Alku P Ilmoniemi RJ Luuk A Allik J Sinkkonen J Alho K Language-specific phoneme representations revealed by electric and magnetic brain responses Nature 1997 385 432-434 
N&#228;&#228;t&#228;nen R Paavilainen P Rinne T Alho K The mismatch negativity (MMN) in basic research of central auditory processing: a review Clinical Neurophysiology 2007 118 2544-2590 
N&#228;&#228;t&#228;nen R Pakarinen S Rinne T Takegata R The mismatch negativity (MMN): towards the optimal paradigm Clinical Neurophysiology 2004 115 140-144 
Oades RD Dittmann-Balcar A Zerbin D Development and topography of auditory event-related potentials (ERPs): mismatch and processing negativity in individuals 8&#8211;22 years of age Psychophysiology 1997 34 677-693 
Picton TW Taylor MJ Electrophysiological evaluation of human brain development Developmental Neuropsychology 2007 31 249-278 
Sauseng P Klimesch W What does phase information of oscillatory brain activity tell us about cognitive processes? Neuroscience and Biobehavioral Reviews 2008 32 1001-1013 
Sayers BM Beagley HA Henshall WR The mechanism of auditory evoked EEG responses Nature 1974 247 481-483 
Sch&#252;rmann M Ba&#351;ar E Topography of alpha and theta oscillations upon auditory and visual stimuli in humans Biological Cybernetics 1994 72 161-174 
Shafer VL Morr ML Kreuzer JA Kurtzberg D Maturation of mismatch negativity in school-aged children Ear and Hearing 2000 21 242-251 
Shahin AJ Roberts LE Chau W Trainor LJ Miller LM Music training leads to the development of timbre-specific gamma band activity NeuroImage 2008 41 113-122 
Shahin AJ Trainor LJ Roberts LE Backer KC Miller LM Development of auditory phase-locked activity for music sounds Journal of Neurophysiology 2010 103 218-229 
Sutcliffe P Bishop DVM Psychophysical design influences frequency discrimination performance in young children Journal of Experimental Child Psychology 2005 91 249-270 
Sutcliffe P Bishop D Houghton S Taylor M Effect of attentional state on frequency discrimination: a comparison of children with ADHD on and off medication Journal of Speech, Language and Hearing Research 2006 49 1072-1084 
Tang AC Sutherland MT McKinney CJ Validation of SOBI components from high-density EEG NeuroImage 2005 25 2 539-553 
Torgesen JK Wagner R Rashotte C Test of Word Reading Efficiency (TOWRE) 1999 New York Psychological Corporation 
Uwer R Albrecht R von Suchodoletz W Automatic processing of tones and speech stimuli in children with specific language impairment Developmental Medicine and Child Neurology 2002 44 527-532 
Wechsler D Wechsler Abbreviated Scale of Intelligence 1999 San Antonio, TX Psychological Corporation 
Werner LA Marean GC Human auditory development 1996 Boulder, CO Westview Press 
Whitford TJ Rennie CJ Grieve SM Clark CR Gordon E Williams LM Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology Human Brain Mapping 2007 28 3 228-237 
Yordanova J Kolev V Schmidt LA , Segalowitz SJ Event-related brain oscillations in normal development Developmental psychophysiology: Theory, systems and methods 2008 New York Cambridge University Press 15-68 
Bruno JJ Ellis JJ Herbal use among US elderly: 2002 National Health Interview Survey Ann Pharmacother 2005 39 643-648 
Slone Epidemiology Center Patterns of Medication Use in the United States 2006. A Report from the Slone Survey 2006 Boston, Mass. Slone Epidemiology Center at Boston University 
CDC Incidence of Diagnosed Diabetes Per 1000 Population Aged 18&#8211;79 Years, by Sex and Age, United States, 1997&#8211;2005 2007 Atlanta, Georgia Centers for Disease Control and Prevention (CDC) Available at:
Marshall S Bacote V Traxinger R Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance J Biol Chem 1991 266 4706-4712 
Copeland RJ Bullen JW Hart GW Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity Am J Physiol Endocrinol Metab 2008 295 E17-E28 
Pham T Cornea A Blick KE Jenkins A Scofield RH Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance Am J Med Sci 2007 333 333-339 
Biggee BA Blinn CM Nuite M Silbert JE McAlindon TE Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis Ann Rheum Dis 2007 66 260-262 
Dahmer S Schiller RM Glucosamine Am Fam Physician 2008 78 471-476 
Shankar RR Zhu J-S Baron AD Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus Metabolism 1998 47 573-577 
Muniyappa R Karne RJ Hall G Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects Diabetes 2006 55 3142-3150 
Quastel JH Intestinal absorption of sugars and amino acids Am J Clin Nutr 1960 8 137-146 
Hastings TH Landau BR Specificity of sugar transport by the intestine of the hamster Am J Physiol 1960 198 99-102 
Neale RJ Wiseman G The use of dietary-restricted rat intestine for active transport studies J Physiol 1969 205 159-178 
Faust RG Leadbetter MG Plenge RK McCaslin AJ Active sugar transport by the small intestine. The effects of sugars, amino acids, hexosamines, sulfhydryl-reacting compounds, and cations on the preferential binding of D-glucose to tris-disrupted brush borders J Gen Physiol 1968 52 482-494 
Hirayama BA Loo DD D&#237;ez-Sampedro A Sodium-dependent reorganization of the sugar-binding site of SGLT1 Biochemistry 2007 46 13391-1406 
Roda A Sabatini L Barbieri A Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma J Chromatogr B 2006 844 119-126 
Biggee BA Blinn CM McAlindon TE Nuite M Silbert JE Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness Ann Rheum Dis 2006 65 222-226 
Persiani S Rotini R Trisolino G Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose Osteoarthritis Cartilage 2007 15 764-772 
Persiani S Roda E Rovati LC Locatelli M Giacovelli G Roda A Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man Osteoarthritis Cartilage 2005 13 1041-1049 
Setnikar I Rovati LC Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review Arzneimittelforschung 2001 51 699-725 
Adebowale A Du J Liang Z Leslie JL Eddington ND The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs Biopharm Drug Dispos 2002 23 217-225 
Du J White N Eddington ND The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse Biopharm Drug Dispos 2004 25 109-116 
Laverty S Sandy JD Celeste C Vachon P Marier J-F Plaas AH Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses Arthritis Rheum 2005 52 181-191 
Aghazadeh-Habashi A Sattari S Pasutto F Jamali F Single dose pharmacokinetics and bioavailability of glucosamine in the rat J Pharm Pharm Sci 2002 5 181-184 
Setnikar I Palumbo R Canali S Zanolo G Pharmacokinetics of glucosamine in man Arzneimittelforschung 1993 43 1109-1113 
Aghazadeh-Habashi A Ibrahim A Carran J Anastassiades T Jamali F Single dose pharmacokinetics and bioavailability of butyryl glucosamine in the rat J Pharm Pharm Sci 2006 9 359-364 
Crociani F Alessandrini A Mucci MM Biavati B Degradation of complex carbohydrates by Bifidobacterium spp Int J Food Microbiol 1994 24 199-210 
Salyers AA Vercellotti JR West SEH Wilkins TD Fermentation of mucin and plant polysaccharides by strains of bacteroides from the human colon Appl Environ Microbiol 1977 33 319-322 
Kajinuma H Kuzuya T Ide T Tyler JM Effects of glucosamine on insulin and glucagon secretion in dogs and ducks Endocrinol Jpn 1975 22 517-523 
Giaccari A Morviducci L Zorretta D In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia Diabetologia 1995 38 518-524 
Baron AD Zhu J-S Zhu J-H Weldon H Maianu L Garvey WT Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: implications for glucose toxicity J Clin Invest 1995 96 2792-2801 
Rossetti L Hawkins M Chen W Gindi J Barzilai N In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats J Clin Invest 1995 96 132-140 
Hawkins M Angelov I Liu R Barzilai N Rossetti L The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake J Biol Chem 1997 272 4889-4895 
Virkam&#228;ki A Daniels MC H&#228;mal&#228;inen S Utriainen T McClain D Yki-J&#228;rvinen H Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues Endocrinology 1997 138 2501-2507 
Holm&#228;ng A Nilsson C Niklasson M Larsson BM Lonroth P Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin Diabetes 1999 48 106-111 
Kim YB Zhu JS Zierath JR Shen HQ Baron AD Kahn BB Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle Diabetes 1999 48 310-320 
Patti ME Virkamaki A Landaker EJ Kahn CR Yki-Jarvinen H Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle Diabetes 1999 48 1562-1571 
Spampinato D Giaccari A Trischitta V Rats that are made insulin resistant by glucosamine treatment have impaired skeletal muscle insulin receptor phosphorylation Metabolism 2003 52 1092-1095 
Robertson MW Dunshea FR Goddard ME Leury BJ Stimulation of the hexosamine biosynthetic pathway by glucosamine in sheep Asia Pac J Clin Nutr 2005 14 suppl S79 
Monauni T Zenti MG Cretti A Effects of glucosamine infusion on insulin secretion and insulin action in humans Diabetes 2000 49 926-935 
Pouwels M-J Jacobs JR Span PN Lutterman JA Smits P Tack CJ Short-term glucosamine infusion does not affect insulin sensitivity in humans J Clin Endocrinol Metab 2001 86 2099-2103 
Oguchi M Miyatake Y Ayabe J Akamatsu N Phosphorylation of D-glucosamine by rat liver glucokinase J Biochem 1975 77 1117-1121 
Agius L Stubbs M Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites Biochem J 2000 346 413-421 
Albert SG Oiknine RF Parseghian S Mooradian AD Haas MJ McPherson T The effect of glucosamine on serum HDL cholesterol and apolipoprotein AI levels in people with diabetes Diabetes Care 2007 30 2800-2803 
Yu JG Boies SM Olefsky JM The effect of oral glucosamine sulfate on insulin sensitivity in human subjects Diabetes Care 2003 26 1941-1942 
Scroggie DA Albright A Harris MD The effect of glucosamine-chondroitin supplementation on glycosylated hemoglobin levels in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial Arch Intern Med 2003 163 1587-1590 
Tapadinhas MJ Rivera IC Bignamini AA Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal Pharmatherapeutica 1982 3 157-168 
Clegg DO Reda DJ Harris CL Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis N Engl J Med 2006 354 795-808 
Tannis AJ Barban J Conquer JA Effect of glucosamine supplementation on fasting and non-fasting plasma glucose and serum insulin concentrations in healthy individuals Osteoarthritis Cartilage 2004 12 506-511 
Hughes R Carr A A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee Rheumatology 2002 41 279-284 
Pavelk&#225; K Gatterova J Olejarova M Machacek S Giacovelli G Rovati LC Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study Arch Intern Med 2002 162 2113-2123 
Reginster JY Deroisy R Rovati LC Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 2001 357 251-256 
Almada AL Harvey P Platt K Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in non-diabetic individuals FASEB J 2000 14 A750 [Abstract 521.15]
Giordano N Nardi P Senesi M Efficacia e tollerabilit&#224; della glucosamina solfato nel trattamento della gonartrosi. [The efficacy and safety of glucosamine sulfate in the treatment of gonarthritis] Clin Ter 1996 147 99-105 
Noack W Fischer M Forster KK Rovati LC Setnikar I Glucosamine sulfate in osteoarthritis of the knee Osteoarthritis Cartilage 1994 2 51-59 
D'Ambrosio E Casa B Bompani R Scali G Scali M Glucosamine sulphate: a controlled clinical investigation in arthrosis Pharmatherapeutica 1981 2 504-508 
Drovanti A Bignamini AA Rovati AL Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation Clin Ther 1980 3 260-272 
Crolle G D'Este E Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation Curr Med Res Opin 1980 7 104-109 
Laferr&#232;re B Garcia-Lorda P Russell CD Pi-Sunyer FX Effect of oral glucosamine sulfate on serum leptin levels in human subjects Nutrition 2004 20 321-322 
Pujalte JM Llavore EP Ylescupidez FR Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis Curr Med Res Opin 1980 7 110-114 
Rovati LC Clinical research in osteoarthritis: design and results of short-term and long-term with disease-modifying drugs Int J Tissue React 1992 14 243-251 
Qiu GX Gao SN Giacovelli G Rovati L Setnikar I Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis Arzneimittelforschung 1998 48 469-474 
Valensi P Schwarz EH Hall M Felton AM Maldonato A Mathieu C Pre-diabetes essential action: a European perspective Diabetes Metab 2005 31 606-620 
IDF Prevalence estimates of diabetes mellitus (DM), 2010 Diabetes Atlas: The e-Atlas 2010 4th edn Brussels, Belgium The International Diabetes Federation (IDF) Available at:
EC Population Statistics: Detailed Tables 2004 Luxembourg Office for Official Publications of the European Communities Available at:
Lee YH Woo JH Choi SJ Ji JD Song GG Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis Rheumatol Int 2010 30 357-363 
Marshall S Nadeau O Yamasaki K Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels J Biol Chem 2004 279 35313-35319 
Heart E Choi WS Sung CK Glucosamine-induced insulin resistance in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab 2000 278 E103-E112 
Echard BW Talpur NA Funk KA Bagchi D Preuss HG Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats Mol Cell Biochem 2001 225 85-91 
McNamara PS Barr SC Erb HN Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days Am J Vet Res 1996 57 1390-1394 
Stender S Astrup P Glucosamine and experimental atherosclerosis. Increased wet weight and charged composition of cholesterol fatty acids in aorta of rabbits fed a cholesterol-enriched diet with added glucosamine Atherosclerosis 1977 26 205-213 
Cryer PE The barrier of hypoglycemia in diabetes Diabetes 2008 57 3169-3176 
Dagogo-Jack SE Craft S Cryer PE Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia J Clin Invest 1993 91 819-828 
Cryer PE Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes Diabetologia 2002 45 937-948 
Davis MR Shamoon H Counterregulatory adaptation to recurrent hypoglycemia in normal humans J Clin Endocrinol Metab 1991 73 995-1001 
Davis SN Mann S Galassetti P Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans Diabetes 2000 49 1897-1903 
Heller SR Cryer PE Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans Diabetes 1991 40 223-226 
Geddes J Wright RJ Zammitt NN Deary IJ Frier BM An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes Diab Care 2007 30 1868-1870 
Pedersen-Bjergaard U Agerholm-Larsen B Pramming S Hougaard P Thorsteinsson B Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus Lancet 2001 357 1248-1253 
Pedersen-Bjergaard U Dhamrait SS Sethi AA Genetic variation and activity of the renin&#8211;angiotensin system and severe hypoglycemia in type 1 diabetes Am J Med 2008 121 246-248 
Schouwenberg BJ Veldman BA Spiering W The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus Pharmacogenet Genomics 2008 18 369-372 
Leineweber K Brodde OE Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes Life Sci 2004 74 2803-2814 
Green SA Turki J Innis M Liggett SB Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 1994 33 9414-9419 
Liggett SB beta(2)-adrenergic receptor pharmacogenetics Am J Respir Crit Care Med 2000 161 S197-S201 
Korytkowski MT Mokan M Veneman TF Mitrakou A Cryer PE Gerich JE Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness Diab Care 1998 21 1939-1943 
Fritsche A Stumvoll M Grub M Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects Diab Care 1998 21 1505-1510 
Berlin I Grimaldi A Payan C Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients Diab Care 1987 10 742-747 
Berlin I Grimaldi A Bosquet F Puech AJ Decreased beta-adrenergic sensitivity in insulin-dependent diabetic subjects J Clin Endocrinol Metab 1986 63 262-265 
Trovik TS Jaeger R Jorde R Sager G Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness Br J Clin Pharmacol 1994 38 427-432 
Schwab KO Menche U Schmeisl G Lohse MJ Hypoglycemia-dependent beta2-adrenoceptor downregulation: a contributing factor to hypoglycemia unawareness in patients with type-1 diabetes? Horm Res 2004 62 137-141 
Trovik TS Vaartun A Jorde R Sager G Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia Eur J Clin Pharmacol 1995 48 327-332 
Trovik TS Jaeger R Jorde R Sager G Reduced beta-adrenergic sensitivity in healthy participants induced by hypoglycemia Fundam Clin Pharmacol 1995 9 181-186 
Liu D Moberg E Kollind M Lins PE Adamson U MacDonald IA Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia Diabetologia 1992 35 287-290 
Deary IJ Hepburn DA MacLeod KM Frier BM Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis Diabetologia 1993 36 771-777 
Galan BE Mol P Wennekes L Schouwenberg BJ Smits P Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness J Clin Endocrinol Metab 2006 91 2878-2881 
Meijer P Wouters CW Broek PH Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation Br J Pharmacol 2008 153 1169-1176 
Lenders J Janssen GJ Smits P Thien T Role of the wrist cuff in forearm plethysmography Clin Sci (Lond) 1991 80 413-417 
Cleaveland CR Rangno RE Shand DG A standardized isoproteranol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol Arch Intern Med 1972 130 47-52 
Miller SA Dykes DD Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16 1215 
Ronaghi M Pyrosequencing for SNP genotyping Methods Mol Biol 2003 212 189-195 
Willemsen JJ Ross HA Jacobs MC Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans Clin Chem 1995 41 1455-1460 
Galan BE Tack CJ Lenders JW Theophylline improves hypoglycemia unawareness in type 1 diabetes Diabetes 2002 51 790-796 
Berlin I Grimaldi A Landault C Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients J Clin Endocrinol Metab 1988 66 273-278 
Macmillan AK Merrie AE Marshall RJ Parry BR The prevalence of fecal incontinence in community-dwelling adults: a systematic review of the literature Dis Colon Rectum 2004 47 1341-1349 
Shafik A Polytetrafluoroethylene injection for the treatment of partial fecal incontinence Int Surg 1993 78 159-161 
Kumar D Benson MJ Bland JE Glutaraldehyde cross-linked collagen in the treatment of faecal incontinence Br J Surg 1998 85 978-979 
Shafik A Perianal injection of autologous fat for treatment of sphincteric incontinence Dis Colon Rectum 1995 38 583-587 
Malouf AJ Vaizey CJ Norton CS Kamm MA Internal anal sphincter augmentation for fecal incontinence using injectable silicone biomaterial Dis Colon Rectum 2001 44 595-600 
Chan MK Tjandra JJ Injectable silicone biomaterial (PTQ) to treat fecal incontinence after hemorrhoidectomy Dis Colon Rectum 2006 49 433-439 
Tjandra JJ Lim JF Hiscock R Rajendra P Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective Dis Colon Rectum 2004 47 2138-2146 
Kenefick NJ Vaizey CJ Malouf AJ Norton CS Marshall M Kamm MA Injectable silicone biomaterial for faecal incontinence due to internal anal sphincter dysfunction Gut 2002 51 225-228 
Davis K Kumar D Poloniecki J Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence Aliment Pharmacol Ther 2003 18 237-243 
Pannek J Brands FH Senge T Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence J Urol 2001 166 1350-1353 
Emans PJ Saralidze K Knetsch ML Gijbels MJ Kuijer R Koole LH Development of new injectable bulking agents: biocompatibility of radiopaque polymeric microspheres studied in a mouse model J Biomed Mater Res A 2005 73 430-436 
Kuang S Kuroda K Grand F Rudnicki MA Asymmetric self-renewal and commitment of satellite stem cells in muscle Cell 2007 129 999-1010 
Qu-Petersen Z Deasy B Jankowski R Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration J Cell Biol 2002 157 851-864 
Lee JY Paik SY Yuk SH Lee JH Ghil SH Lee SS Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves Mol Cells 2004 18 309-313 
Cannon TW Lee JY Somogyi G Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra Urology 2003 62 958-963 
Yiou R Yoo JJ Atala A Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts Transplantation 2003 76 1053-1060 
Kwon D Kim Y Pruchnic R Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence Urology 2006 68 449-454 
Lee JY Cannon TW Pruchnic R Fraser MO Huard J Chancellor MB The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence Int Urogynecol J Pelvic Floor Dysfunct 2003 14 31-37 
Yiou R Dreyfus P Chopin DK Abbou CC Lefaucheur JP Muscle precursor cell autografting in a murine model of urethral sphincter injury BJU Int 2002 89 298-302 
Chermansky CJ Tarin T Kwon DD Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency Urology 2004 63 780-785 
Strasser H Marksteiner R Margreiter E Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomised controlled trial Lancet 2007 369 2179-2186 
Garcia-Olmo D Garcia-Arranz M Garcia LG Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn&#8217;s disease: a new cell-based therapy Int J Colorectal Dis 2003 18 451-454 
Garcia-Olmo D Garcia-Arranz M Herreros D Pascual I Peiro C Rodriguez-Montes JA A phase I clinical trial of the treatment of Crohn&#8217;s fistula by adipose mesenchymal stem cell transplantation Dis Colon Rectum 2005 48 1416-1423 
Rando TA Blau HM Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy J Cell Biol 1994 125 1275-1287 
Huard J Yokoyama T Pruchnic R Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction Gene Ther 2002 9 1617-1626 
Gulbins H Pritisanac A Anderson I Myoblasts for survive 16 weeks after intracardiac transfer and start differentiation Thorac Cardiovasc Surg 2003 51 295-300 
Hwang JH Yuk SH Lee JH Isolation of muscle derived stem cells from rat and its smooth muscle differentiation Mol Cells 2004 17 57-61 
Qu Z Balkir L Deutekom JC Robbins PD Pruchnic R Huard J Development of approaches to improve cell survival in myoblast transfer therapy J Cell Biol 1998 142 1257-1267 
Beauchamp JR Heslop L Yu DS Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells J Cell Biol 2000 151 1221-1234 
Yokoyama T Huard J Chancellor MB Myoblast therapy for stress urinary incontinence and bladder dysfunction World J Urol 2000 18 56-61 
Hag&#232;ge AA Carrion C Menasch&#233; P Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy Lancet 2003 361 491-492 
Alameddine HS Louboutin JP Dehaupas M Sebille A Fardeau M Functional recovery induced by satellite cell grafts in irreversibly injured muscles Cell Transplant 1994 3 3-14 
Guettier-Sigrist S Coupin G Warter JM Poindron P Cell types required to efficiently innervate human muscle cells in vitro Exp Cell Res 2000 259 204-212 
Alessandri G Pagano S Bez A Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages Lancet 2004 364 1872-1883 
